Search intent
Why patients usually ask about this
For patients exploring CAR-T availability, eligibility, hospital review, admission planning, cost questions, or follow-up after returning home.
China angle
Why this can be worth comparing in China
Public and private Shanghai providers have reported international CAR-T cases and cell-therapy activity, but eligibility is highly case-specific.
Who this may help
- Patients with relapsed or refractory hematologic cancers seeking a structured inquiry.
- Families trying to understand documentation, hospitalization, infection-risk monitoring, and follow-up logistics.
- Patients who need a realistic question list before assuming China is suitable.
Records to prepare
- Diagnosis history, pathology, bone marrow reports, cytogenetics, molecular testing, and disease status.
- Complete prior treatment timeline, including chemotherapy, immunotherapy, transplant, radiation, and response history.
- Recent blood work, organ function, infection history, performance status, and current medications.
- Insurance or self-pay constraints, caregiver availability, and preferred travel window.
Questions to verify before travel
- Does the center review international records remotely?
- Which product or protocol might be relevant, if any?
- What tests must be repeated in China before eligibility can be assessed?
- What hospitalization, caregiver, infection-monitoring, and post-discharge follow-up expectations apply?